GATA2 and leukemia: Results from in vivo serial transplants of these cells into NSG-S mice suggest that germline GATA2 mutation alone is not sufficient to promote leukemia, however in combination with SETBP1+ASXL mutations a higher engraftment potential was observed in secondary transplants.